Clinical Research A new class of Immuno-Oncology Scoring Services

for academic, clinical centers and biopharmaceutical companies

Why Immuno-Oncology Scoring Solutions ?

Identifying the right patient/therapy combination is a major challenge for healthcare professionals in the field of cancer.

HalioDx immuno-oncology (IO) scoring solutions are designed to better understand the mechanism of action of the drugs and identify different groups of patients: Identify responders or resistant patients.

Parameters used in IO scoring

Adapted from Galon et al. Immunity 2013

HalioDx services/assays can be used in prospective clinical trials or in retrospectives studies.